| D007223 |
Infant |
A child between 1 and 23 months of age. |
Infants |
|
| D002648 |
Child |
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. |
Children |
|
| D002675 |
Child, Preschool |
A child between the ages of 2 and 5. |
Children, Preschool,Preschool Child,Preschool Children |
|
| D004827 |
Epilepsy |
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) |
Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders |
|
| D005240 |
Feasibility Studies |
Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. |
Feasibility Study,Studies, Feasibility,Study, Feasibility |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000927 |
Anticonvulsants |
Drugs used to prevent SEIZURES or reduce their severity. |
Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic |
|
| D014794 |
Visual Fields |
The total area or space visible in a person's peripheral vision with the eye looking straightforward. |
Field, Visual,Fields, Visual,Visual Field |
|
| D058609 |
Visual Field Tests |
Method of measuring and mapping the scope of vision, from central to peripheral of each eye. |
Automated Perimetry Exam,Campimetry,Perimetry,Tangent Screen Exam,Visual Field Exam,Automated Perimetry Exams,Campimetries,Exam, Automated Perimetry,Exam, Tangent Screen,Exam, Visual Field,Exams, Automated Perimetry,Exams, Tangent Screen,Exams, Visual Field,Field Exam, Visual,Field Exams, Visual,Field Test, Visual,Field Tests, Visual,Perimetries,Perimetry Exam, Automated,Perimetry Exams, Automated,Screen Exam, Tangent,Screen Exams, Tangent,Tangent Screen Exams,Test, Visual Field,Tests, Visual Field,Visual Field Exams,Visual Field Test |
|
| D020888 |
Vigabatrin |
An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID and is used as an anticonvulsant. (From Martindale The Extra Pharmacopoeia, 31st ed) |
gamma-Vinyl-gamma-Aminobutyric Acid,Sabril,Sabrilex,gamma-Vinyl-GABA,gamma Vinyl GABA,gamma Vinyl gamma Aminobutyric Acid |
|